A method of analyzing nucleic acid by compensating for crosstalk in polymerase chain reaction (PCR) data and other data, wherein crosstalk signals associated with multiple fluorescent dyes are corrected by using fluorescent intensity variations detected from a concentration difference of the fluorescent dyes, and apparatus for performing the method.
|
1. A nucleic acid analysis method comprising:
detecting fluorescent intensity variations in nucleic acids labeled with fluorescent dyes;
calculating initial threshold cycles (CTs) corresponding to each of different fluorescent dyes labeled on a nucleic acid, from fluorescent intensity variations detected from the fluorescent dyes;
calculating a difference in concentration between the fluorescent dyes from a difference between the calculated initial CTS;
correcting previously stored crosstalk signals corresponding to each of the fluorescent dyes based on a fluorescent intensity correction value calculated from the calculated difference in concentration; and
estimating final threshold cycles of the fluorescent dyes based on the corrected crosstalk signals.
2. The method of
wherein calculating the difference in the concentration comprises calculating the difference in concentration if it is determined that the calculated initial threshold cycles are not the same.
3. The method of
4. The method of
wherein the nth-order differentiation method comprises a method for determining a threshold cycle as a maximum value of an nth-order differentiation curve of a curve indicating the fluorescent intensity variations, and
wherein the threshold method comprises a method for determining a threshold cycle as an x-axis value of an intersection between a threshold line parallel to an x-axis and the curve indicating the fluorescent intensity variations.
5. The method of
6. The method of
7. The method of
8. The method of
9. A non-transitory computer-readable recording medium having recorded thereon a computer program for executing the method of
|
This application claims the benefit of Korean Patent Application No. 10-2012-0070234, filed on Jun. 28, 2012, in the Korean Intellectual Property Office, the disclosure of which is incorporated herein in its entirety by reference.
1. Field
The present disclosure relates to methods and apparatuses for analyzing nucleic acid by compensating for crosstalk in polymerase chain reaction (PCR) data, microarray data, etc.
2. Description of the Related Art
Polymerase chain reaction (PCR) is currently used in almost all tests for manipulating a genetic material, and is a method of amplifying a certain target genetic material to be detected. Since a small amount of a genetic material having the same base sequence may be amplified to a large amount, PCR is used to diagnose various genetic diseases by amplifying nucleic acids such as deoxyribonucleic acid (DNA) of humans. Also, infectious diseases may be diagnosed by using PCR for nucleic acid of bacteria, viruses, or fungi.
In general, PCR includes three steps: performing denaturation to separate two strands of DNA by using heat, reducing temperature to anneal a primer to an end of a sequence to be amplified and slightly increasing temperature to cause polymerization or extension for synthesizing DNA. Since the amount of a genetic material is doubled by performing PCR once, if PCR is performed repeatedly, the amount of nucleic acid may be amplified geometrically.
Recently, multiplex PCR (real-time multiplex PCR) for amplifying multiple target genetic material by using different fluorescent dyes or probes has been introduced. In order to obtain a test result using multiplex PCR, filters for detecting certain wavelength bands of different colors of fluorescent light emitted from different fluorescent dyes are used. However, since these filters have adjacent wavelength bands, crosstalk may occur due to fluorescent signals of adjacent bands, and thus, an accurate test result may not be easily obtained. Accordingly, research is being conducted on how to perform accurate analysis of nucleic acid in consideration of crosstalk.
Provided are methods and apparatuses for analyzing nucleic acid by compensating for crosstalk in polymerase chain reaction (PCR) data, microarray data, etc.
In one aspect, there is provided a nucleic acid analysis method comprising: obtaining (e.g., by detecting) a difference in concentration between different fluorescent dyes labeled on a nucleic acid by using (e.g., by measuring) a difference between fluorescent intensity variations detected from the fluorescent dyes; correcting crosstalk signals due to the fluorescent dyes by using the obtained (detected) difference in concentration; and estimating (calculating) final threshold cycles of the fluorescent dyes by compensating for the detected fluorescent intensity variations by using the corrected crosstalk signals.
Also provided is a non-transitory computer-readable recording media having recorded thereon a computer program for executing the method.
According to another aspect of the present invention, a nucleic acid analysis apparatus is provided, which includes a concentration analysis unit that obtains (e.g., by detecting) a difference in concentration between different fluorescent dyes labeled on a nucleic acid by using (e.g., by measuring) a difference between fluorescent intensity variations detected from the fluorescent dyes; a correction unit that corrects crosstalk signals due to the fluorescent dyes by using the obtained (detected) difference in concentration; and an estimation unit that estimates final threshold cycles of the fluorescent dyes by compensating for the detected fluorescent intensity variations by using the corrected crosstalk signals.
Additional aspects will be set forth in part in the description which follows and, in part, will be apparent from the description, or may be learned by practice of the presented embodiments.
These and/or other aspects will become apparent and more readily appreciated from the following description of the embodiments, taken in conjunction with the accompanying drawings of which:
Reference will now be made in detail to embodiments, examples of which are illustrated in the accompanying drawings, wherein like reference numerals refer to the like elements throughout. In this regard, the present embodiments may have different forms and should not be construed as being limited to the descriptions set forth herein. Accordingly, the embodiments are merely described below, by referring to the figures, to explain aspects of the present description. As used herein, expressions such as “at least one of,” when preceding a list of elements, modify the entire list of elements and do not modify the individual elements of the list.
The nucleic acid analysis system 1 is a system for analyzing by using the nucleic acid analysis apparatus 10 a plurality of fluorescent signals detected from different fluorescent dyes labeled on a nucleic acid sample by the PCR device 21 or the microarray 22. As a result, quantitative analysis information 30 of nucleic acid is generated.
From among various analysis methods of detecting nucleic acid from a deoxyribonucleic acid (DNA) sample and quantitating the nucleic acid, a PCR (a real-time multiplex PCR) is one of the most commonly used methods and is well known to one of ordinary skill in the art.
The PCR device 21 is a device for exponentially amplifying a nucleic acid by performing three steps: performing denaturation to separate two strands of DNA by using heat, reducing temperature to anneal a primer to an end of a sequence to be amplified, and slightly increasing temperature again to cause polymerization or extension for synthesizing DNA. In particular, the PCR device 21 uses real-time PCR for quantitative analysis of a nucleic acid by detecting in real time the intensity of a fluorescent signal that is proportional to the concentration of the amplified nucleic acid.
Currently, real-time multiplex PCR for amplifying a target genetic material by using different fluorescent dyes is also used in many instances. In order to obtain a test result using a multiplex PCR, filters for detecting a certain wavelength band of each of different colors of fluorescent light emitted from different fluorescent dyes.
As described above, even when fluorescent filter bands are optimally designed to minimize crosstalk, since fluorescent signals regarding fluorescent dyes interfere with each other due to the crosstalk, if the number of colors of fluorescent light to be detected is increased, a test result, e.g., a result of quantitating nucleic acid, may not be accurately obtained. Accordingly, an analysis result of nucleic acid needs to be accurately analyzed in consideration of crosstalk.
Typical multiplex PCR using a plurality of fluorescent dyes has been suggested in consideration of crosstalk between detected fluorescent signals. However, the crosstalk is considered regardless of the difference in concentration between fluorescent dyes on the assumption that the fluorescent dyes have the same concentration.
In actuality, however, in multiplex PCR, fluorescent dyes may have different concentrations intentionally or unintentionally. Since a fluorescent dye having a high concentration may have much crosstalk due to other fluorescent dyes, in order to accurately obtain an analysis result of nucleic acid, crosstalk has to be reflected in consideration of the concentrations of fluorescent dyes.
Accordingly, the nucleic acid analysis apparatus 10 of the nucleic acid analysis system 1 is an apparatus capable of obtaining a more accurate result of analyzing nucleic acid by reflecting crosstalk in consideration of concentrations of fluorescent dyes when a plurality of fluorescent dyes are simultaneously used by the PCR device 21 or the microarray 22.
The PCR device 21 of the nucleic acid analysis system 1 may be a device for performing multiplex PCR, and the microarray 22 may be a device using different fluorescent dyes in every spot. Also, a microfluidic device using different fluorescent dyes in one chamber may be used instead of the PCR device 21 or the microarray 22.
That is, it would be understood by one of ordinary skill in the art that the nucleic acid analysis system 1 may use any device other than the PCR device 21 or the microarray 22 as long as the device detects fluorescent signals from different fluorescent dyes labeled on nucleic acid. Although the structure and operation of the nucleic acid analysis apparatus 10 will be described below on the assumption that the PCR device 21 for performing multiplex PCR is used, it would be understood by one of ordinary skill in the art that the nucleic acid analysis apparatus 10 is not limited thereto.
In particular, the nucleic acid analysis apparatus 10 illustrated in
The measurement unit 110 receives a result of detecting colors of fluorescent light emitted form different fluorescent dyes labeled on nucleic acid by the PCR device 21 or the microarray 22, and measures fluorescent intensity variations. A process of measuring the fluorescent intensity variations according to fluorescent signals output from the PCR device 21 or the microarray 22 is well known to one of ordinary skill in the art, and thus a detailed description thereof is not provided here.
Meanwhile, it is described above in relation to
Referring to
According to
Five points plateau refers to values (fluorescence intensities) of five arbitrary points in a graph of
The nucleic acid analysis apparatus 10 may previously store in a storage (not shown) results of performing single-plex PCR on each of the fluorescent dyes as calibration information.
Referring back to
Although 2-plex PCR using FAM dye and Cal Fluor 560 dye is representatively described below for convenience of explanation, it would be understood by one of ordinary skill in the art that the same principle may also be applied to 3-plex PCR, 4-plex PCR, 5-plex PCR, 6-plex PCR, etc.
The curves shown in
Referring back to
Generally, a threshold cycle CT
The calculation unit 120 calculates a cycle number corresponding to a peak value of the differentiation curve regarding FAM dye as an initial threshold cycle regarding FAM dye (initial CT
According to the graph shown in
Different values are calculated as the initial CT
Referring back to
Differently from the above description, if the initial CT
For example, if the determination unit 130 determines that the initial CTs are the same, the estimation unit 160 may estimate the final CTs by using Equation 2.
S1=(B1−a12B2)/(1−a12·a21)
S2=(B2−a21B1)/(1−a12·a21) [Equation 2]
Referring to Equation 2, S1 refers to a corrected signal of a first dye, S2 refers to a corrected signal of a second dye, B1 refers to an uncorrected signal of the first dye, B2 refers to an uncorrected signal of the second dye, a12 refers to a correction coefficient for correcting crosstalk due to the second dye, and a21 refers to a correction coefficient for correcting crosstalk due to the first dye.
However, if the determination unit 130 determines that the initial CT
The concentration analysis unit 140 obtains the difference in concentration between the fluorescent dyes by using the difference between fluorescent intensity variation curves. That is, the concentration analysis unit 140 obtains the difference in concentration between FAM dye and Cal Fluor 560 dye by using the difference between the initial CT
The concentration analysis unit 140 may obtain the difference in concentration by using Equation 3.
[Δn]=(1+E)ΔC
Referring to Equation 3, Δn refers to the difference in concentration between fluorescent dyes, E refers to an amplification efficiency of PCR, and ΔCT refers to the difference between initial threshold cycles.
According to the above-described example of
The correction unit 150 corrects the crosstalk signals due to the fluorescent dyes by using the obtained difference in concentration. Here, the corrected crosstalk signals are signals corrected by reflecting the difference in concentration obtained by the concentration analysis unit 140 to the crosstalk signals previously stored and obtained when the fluorescent dyes are individually used.
In more detail, the correction unit 150 adjusts the fluorescent intensity variation curves of the crosstalk signals due to the fluorescent dyes by using the difference in concentration obtained by the concentration analysis unit 140, thereby correcting the crosstalk signals. After that, the correction unit 150 readjusts the adjusted result by using the difference between initial threshold cycles of the fluorescent dyes, thereby correcting the crosstalk signals.
Initially, the correction unit 150 corrects fluorescent intensities of the fluorescent dyes by using Equation 4.
IF=I0·QY·(1−e−2.303·ε·c·L)·k
IΔF=(1−e−2.303·c1)/(1−e−2.303·c2) [Equation 4]
QY: Fluorescence quantum yield
ε: Molar extinction coefficient of fluorescence at λEX
c: Fluorescence concentration
L: Optical path length for excitation
I0: Excitation source intensity at λEX
k: Fluorescence collection efficiency
Referring to Equation 4, IΔF corresponds to a fluorescent intensity correction value, IF corresponds to a fluorescent intensity, c1 corresponds to a fluorescence concentration of FAM dye, and c2 corresponds to a fluorescence concentration of Cal Fluor 560 dye.
According to the above-described example of
After that, the correction unit 150 corrects the fluorescent intensity variation curves regarding FAM dye and Cal Fluor 560 dye.
A process whereby the correction unit 150 corrects the fluorescent intensity variation curve regarding Cal Fluor 560 dye is as described below. The correction unit 150 corrects the crosstalk signal due to FAM dye by using Equation 5, and then corrects the fluorescent intensity variation curve regarding Cal Fluor 560 dye by using Equation 6.
FAM_corrected flu. intensity=2plex·a21·IΔF
FAM_corrected con.=FAM_corrected flu. intensity−ΔCT [Equation 5]
Cal560_corrected=2plex−FAM_corrected con. [Equation 6]
Referring to Equation 5, “2plex” corresponds to FAM dye & Cal 560 dye, and “FAM_corrected con.” corresponds to a cross-talk signal by concentration-corrected FAM dye. Each value corresponds to a graph regarding fluorescent intensities of FAM dye. “Cal560_corrected” corresponds to a result of correcting a fluorescent intensity variation curve regarding Cal Fluor 560 dye.
As such, the corrected variation curve 705 is hardly different from an actual variation curve 706 regarding Cal Fluor 560 dye. That is, since the correction unit 150 corrects the original variation curve 704 in consideration of the difference in concentration between fluorescent dyes, a test result close to the actual variation curve 706 may be obtained. Accordingly, a nucleic acid may be analyzed more accurately.
Referring back to
The estimation unit 160 estimates the final CT
Meanwhile, a process of correcting a fluorescent intensity variation curve regarding FAM dye in the correction unit 150 is as described below. The correction unit 150 corrects a crosstalk signal due to Cal Fluor 560 dye by using Equation 7, and then corrects a fluorescent intensity variation curve regarding FAM dye by using Equation 8.
Cal560_corrected flu. intensity=2plex·a12/IΔF
Cal560_corrected con.=Cal560_corrected flu. intensity+ΔCT [Equation 7]
FAM_corrected=2plex−Cal560_corrected con. [Equation 8]
As such, the corrected variation curve 805 is hardly different from an actual variation curve 806 regarding FAM dye. That is, since the correction unit 150 corrects the original variation curve 804 in consideration of the difference in concentration between fluorescent dyes, a test result close to the actual variation curve 806 may be obtained. Accordingly, a nucleic acid may be analyzed more accurately.
Referring back to
According to the above-described example, the estimation unit 160 estimates the final CT
When compared, the threshold cycles regarding Cal Fluor 560 are particularly different. The difference is caused by the difference in concentration between FAM dye and Cal Fluor 560 dye, and is less than the difference between the threshold cycles calculated without considering the difference in concentration.
Although 4-plex PCR is not described in detail here, it would be understood by one of ordinary skill in the art that 4-plex PCR may be easily performed by using 2-plex PCR described above.
Meanwhile, the above graphs and values regarding FAM dye and Cal Fluor 560 dye are merely examples provided to promote an understanding of embodiments of the present invention, and it would be understood by one of ordinary skill in the art that the embodiments of the present invention are not limited thereto.
In operation 1101, the concentration analysis unit 140 obtains the difference in concentration between different fluorescent dyes labeled on nucleic acid by using the difference between fluorescent intensity variation curves detected from the fluorescent dyes.
In operation 1102, the correction unit 150 corrects crosstalk signals due to the fluorescent dyes by using the obtained difference in concentration.
In operation 1103, the estimation unit 160 estimates final threshold cycles of the fluorescent dyes by compensating the detected fluorescent intensity variation curves by using the corrected crosstalk signals.
As described above, according to one or more of the above embodiments of the present invention, when a nucleic acid is analyzed by using different fluorescent dyes, since crosstalk signals may be accurately corrected by reflecting the difference in concentration between fluorescent dyes, a more accurate result of analyzing the nucleic acid may be obtained.
Meanwhile, embodiments of the present invention can be written as computer programs and can be implemented in general-use digital computers that execute the programs using a computer readable recording medium. Also, the data structure used in the embodiments of the present invention described above can be recorded on a computer readable recording medium via various means. Examples of the computer readable recording medium include information storage media (e.g., ROM, floppy disks, hard disks, etc.), optical recording media (e.g., CD-ROMs, or DVDs), etc.
All references, including publications, patent applications, and patents, cited herein are hereby incorporated by reference to the same extent as if each reference were individually and specifically indicated to be incorporated by reference and were set forth in its entirety herein.
The use of the terms “a” and “an” and “the” and “at least one” and similar referents in the context of describing the invention (especially in the context of the following claims) are to be construed to cover both the singular and the plural, unless otherwise indicated herein or clearly contradicted by context. The use of the term “at least one” followed by a list of one or more items (for example, “at least one of A and B”) is to be construed to mean one item selected from the listed items (A or B) or any combination of two or more of the listed items (A and B), unless otherwise indicated herein or clearly contradicted by context. The terms “comprising,” “having,” “including,” and “containing” are to be construed as open-ended terms (i.e., meaning “including, but not limited to,”) unless otherwise noted. Recitation of ranges of values herein are merely intended to serve as a shorthand method of referring individually to each separate value falling within the range, unless otherwise indicated herein, and each separate value is incorporated into the specification as if it were individually recited herein. All methods described herein can be performed in any suitable order unless otherwise indicated herein or otherwise clearly contradicted by context. The use of any and all examples, or exemplary language (e.g., “such as”) provided herein, is intended merely to better illuminate the invention and does not pose a limitation on the scope of the invention unless otherwise claimed. No language in the specification should be construed as indicating any non-claimed element as essential to the practice of the invention.
Preferred embodiments of this invention are described herein, including the best mode known to the inventors for carrying out the invention. Variations of those preferred embodiments may become apparent to those of ordinary skill in the art upon reading the foregoing description. The inventors expect skilled artisans to employ such variations as appropriate, and the inventors intend for the invention to be practiced otherwise than as specifically described herein. Accordingly, this invention includes all modifications and equivalents of the subject matter recited in the claims appended hereto as permitted by applicable law. Moreover, any combination of the above-described elements in all possible variations thereof is encompassed by the invention unless otherwise indicated herein or otherwise clearly contradicted by context.
Kim, Joon-Ho, Kim, Kyung-ho, Lee, Soo-Kwan, Namkoong, Kak, Chung, Won-seok, Jung, Sun-ok
Patent | Priority | Assignee | Title |
Patent | Priority | Assignee | Title |
7209836, | Jul 16 1999 | Packard Bioscience Company | Method and system for automatically creating crosstalk-corrected data of a microarray |
7839507, | Jun 28 2006 | Applied Biosystems, LLC | Minimizing effects of dye crosstalk |
8095322, | Jun 29 2007 | Roche Molecular Systems, Inc | Systems and methods for determining cross-talk coefficients in PCR and other data sets |
20090035779, | |||
WO2011031585, |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Jan 15 2013 | KIM, KYUNG-HO | SAMSUNG ELECTRONICS CO , LTD | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 029752 | /0503 | |
Jan 15 2013 | LEE, SOO-KWAN | SAMSUNG ELECTRONICS CO , LTD | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 029752 | /0503 | |
Jan 15 2013 | KIM, JOON-HO | SAMSUNG ELECTRONICS CO , LTD | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 029752 | /0503 | |
Jan 15 2013 | NAMKOONG, KAK | SAMSUNG ELECTRONICS CO , LTD | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 029752 | /0503 | |
Jan 15 2013 | JUNG, SUN-OK | SAMSUNG ELECTRONICS CO , LTD | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 029752 | /0503 | |
Jan 15 2013 | CHUNG, WON-SEOK | SAMSUNG ELECTRONICS CO , LTD | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 029752 | /0503 | |
Jan 30 2013 | Samsung Electronics Co., Ltd. | (assignment on the face of the patent) | / |
Date | Maintenance Fee Events |
Mar 07 2019 | M1551: Payment of Maintenance Fee, 4th Year, Large Entity. |
Mar 08 2023 | M1552: Payment of Maintenance Fee, 8th Year, Large Entity. |
Date | Maintenance Schedule |
Sep 22 2018 | 4 years fee payment window open |
Mar 22 2019 | 6 months grace period start (w surcharge) |
Sep 22 2019 | patent expiry (for year 4) |
Sep 22 2021 | 2 years to revive unintentionally abandoned end. (for year 4) |
Sep 22 2022 | 8 years fee payment window open |
Mar 22 2023 | 6 months grace period start (w surcharge) |
Sep 22 2023 | patent expiry (for year 8) |
Sep 22 2025 | 2 years to revive unintentionally abandoned end. (for year 8) |
Sep 22 2026 | 12 years fee payment window open |
Mar 22 2027 | 6 months grace period start (w surcharge) |
Sep 22 2027 | patent expiry (for year 12) |
Sep 22 2029 | 2 years to revive unintentionally abandoned end. (for year 12) |